Your browser doesn't support javascript.
loading
External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification.
Arjona-Sanchez, A; Martinez-López, A; Moreno-Montilla, M T; Mulsow, J; Lozano-Lominchar, P; Martínez-Torres, B; Rau, B; Canbay, E; Sommariva, A; Milione, M; Deraco, M; Sgarbura, O; Torgunrud, A; Kepenekian, V; Carr, N J; Hoorens, A; Delhorme, J B; Wernert, R; Goere, D; Martin-Roman, L; Cosyns, S; Flatmark, K; Davidson, B; Khellaf, L; Pereira-Perez, F; Rodriguez-Ortiz, L; Ibáñez-Costa, A; Romero-Ruiz, A.
Affiliation
  • Arjona-Sanchez A; Unit of Surgical Oncology, Department of Surgery, Reina Sofia University Hospital, Spain; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain. Electronic address: https://twitter.com/alarjosan.
  • Martinez-López A; Unit of Surgical Oncology, Department of Surgery, Reina Sofia University Hospital, Spain; Pathology Unit, Reina Sofia University Hospital, Spain.
  • Moreno-Montilla MT; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain.
  • Mulsow J; National Centre for Peritoneal Malignancy, Mater Hospital, Dublin, Ireland.
  • Lozano-Lominchar P; Department of General Surgery, Peritoneal Carcinomatosis, Sarcoma and Complex Pelvis Cases, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
  • Martínez-Torres B; Department of General Surgery, Hospital University Fuenlabrada, Madrid, Spain.
  • Rau B; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität, Department of Special Surgical Oncology, Berlin, Germany.
  • Canbay E; NPO HIPEC Istanbul centre for Peritoneal Surface Malignancies, Istambul, Turkey.
  • Sommariva A; Advanced Surgical Oncology Unit Surgical Oncology of the Esophagus and Digestive Tract, Veneto Institute of Oncology IOV-IRCCS Padova, Italy.
  • Milione M; Pathology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Deraco M; Peritoneal Surfaces Malignance Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Sgarbura O; Department of Surgical Oncology, Cancer Institute of Montpellier, University of Montpellier, IRCM, Institut de Recherche en Cancérologie de Montpellier, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France.
  • Torgunrud A; Department of Tumor Biology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Kepenekian V; Unit of Surgery, Hospitaux du Lyon, France.
  • Carr NJ; Pathology Department, Peritoneal Malignancy Institute Basingstoke, UK.
  • Hoorens A; Department of Pathology, Ghent University Hospital, Ghent, Belgium.
  • Delhorme JB; Department of general and digestive surgery, Hautepierre Hospital, Hôpitaux universitaires de Strasbourg, France.
  • Wernert R; Surgical Oncology, ICO Paul Papin, Angers, France.
  • Goere D; Digestive Surgery, APHP Hopital Saint Louis, France.
  • Martin-Roman L; National Centre for Peritoneal Malignancy, Mater Hospital, Dublin, Ireland.
  • Cosyns S; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
  • Flatmark K; Department of Gastorenterological Surgery, The Norwegian Radium Hospital, Oslo university Hospital, Oslo, Norway.
  • Davidson B; Department of Pathology, The Norwegian Radium Hospital, Oslo university Hospital, Oslo Norway. University of Oslo, Faculty of Medicine, Institute of Clinical Medicine, N-0316, Oslo, Norway.
  • Khellaf L; Department of Pathology, Cancer Institute of Montpellier, University of Montpellier, Montpellier, France.
  • Pereira-Perez F; Department of General Surgery, Hospital University Fuenlabrada, Madrid, Spain.
  • Rodriguez-Ortiz L; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain; Digestive Surgery, APHP Hopital Saint Louis, France.
  • Ibáñez-Costa A; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain.
  • Romero-Ruiz A; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain. Electronic address: b72rorua@uco.es.
Eur J Surg Oncol ; 49(8): 1481-1488, 2023 08.
Article in En | MEDLINE | ID: mdl-36935222
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peritoneal Neoplasms / Pseudomyxoma Peritonei Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Surg Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peritoneal Neoplasms / Pseudomyxoma Peritonei Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Surg Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: